Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.

Existing observational studies provide conflicting evidence for the causal effect of metformin use on cancer risk in patients with type-2 diabetes, and there are concerns about bias affecting a number of studies.